{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T12:16:34Z","timestamp":1788264994570,"version":"build-2803163510"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T00:00:00Z","timestamp":1785110400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82373904"],"award-info":[{"award-number":["82373904"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["2024212001"],"award-info":[{"award-number":["2024212001"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neoplasia"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.neo.2026.101346","type":"journal-article","created":{"date-parts":[[2026,8,2]],"date-time":"2026-08-02T18:48:39Z","timestamp":1785696519000},"page":"101346","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Foretinib triggers immunogenic cell death and enhances efficacy of anti-CD47 immunotherapy in colorectal cancer"],"prefix":"10.1016","volume":"80","author":[{"given":"Lin","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nannan","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jieran","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyun","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianqian","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-6849-4790","authenticated-orcid":false,"given":"Jingshan","family":"Tong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neo.2026.101346_bib0001","first-page":"10","article-title":"Cancer statistics, 2025","volume":"75","author":"Siegel","year":"2025","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.neo.2026.101346_bib0002","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1007\/s10555-023-10158-3","article-title":"Colorectal cancer: a comprehensive review of carcinogenesis, diagnosis, and novel strategies for classified treatments","volume":"43","author":"Abedizadeh","year":"2024","journal-title":"Cancer Metastasis Rev."},{"key":"10.1016\/j.neo.2026.101346_bib0003","doi-asserted-by":"crossref","first-page":"495","DOI":"10.4240\/wjgs.v15.i4.495","article-title":"Current and emerging therapeutic approaches for colorectal cancer: a comprehensive review","volume":"15","author":"Kumar","year":"2023","journal-title":"World J. Gastrointest. Surg."},{"key":"10.1016\/j.neo.2026.101346_bib0004","article-title":"Immunotherapy in colorectal cancer: statuses and strategies","volume":"11","author":"Li","year":"2025","journal-title":"Heliyon"},{"key":"10.1016\/j.neo.2026.101346_bib0005","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/s12964-023-01430-8","article-title":"New immunotherapy approaches for colorectal cancer: focusing on CAR-T cell, BiTE, and oncolytic viruses","volume":"22","author":"Kamrani","year":"2024","journal-title":"Cell Commun. Signaling"},{"key":"10.1016\/j.neo.2026.101346_bib0006","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2025.104775","article-title":"Immunotherapy in microsatellite-stable colorectal cancer: strategies to overcome resistance","volume":"212","author":"Chen","year":"2025","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.neo.2026.101346_bib0007","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1007\/s12029-023-00927-2","article-title":"Immune checkpoint inhibitors in pMMR\/MSS colorectal cancer","volume":"54","author":"El Hajj","year":"2023","journal-title":"J. Gastrointest. Cancer"},{"key":"10.1016\/j.neo.2026.101346_bib0008","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/s41423-024-01245-8","article-title":"Immunogenicity of cell death and cancer immunotherapy with immune checkpoint inhibitors","volume":"22","author":"Catanzaro","year":"2025","journal-title":"Cell Mol. Immunol."},{"key":"10.1016\/j.neo.2026.101346_bib0009","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/s41568-024-00674-x","article-title":"Immunogenic cell death in cancer: targeting necroptosis to induce antitumour immunity","volume":"24","author":"Meier","year":"2024","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.neo.2026.101346_bib0010","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1038\/s41419-020-03221-2","article-title":"Detection of immunogenic cell death and its relevance for cancer therapy","volume":"11","author":"Fucikova","year":"2020","journal-title":"Cell Death. Dis."},{"key":"10.1016\/j.neo.2026.101346_bib0011","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/s41423-024-01245-8","article-title":"Immunogenicity of cell death and cancer immunotherapy with immune checkpoint inhibitors","volume":"22","author":"Catanzaro","year":"2025","journal-title":"Cell Mol. Immunol."},{"key":"10.1016\/j.neo.2026.101346_bib0012","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5301\/tj.5000675","article-title":"The inducers of immunogenic cell death for tumor immunotherapy","volume":"104","author":"Li","year":"2018","journal-title":"Tumori."},{"key":"10.1016\/j.neo.2026.101346_bib0013","doi-asserted-by":"crossref","DOI":"10.1016\/j.ccr.2025.216846","article-title":"Immunogenic cell death inducers:current advances and future perspectives","volume":"542","author":"Lv","year":"2025","journal-title":"Coord. Chem. Rev."},{"key":"10.1016\/j.neo.2026.101346_bib0014","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1002\/mc.23183","article-title":"Immunogenic cell death in colon cancer prevention and therapy","volume":"59","author":"Ruan","year":"2020","journal-title":"Mol. Carcinog."},{"key":"10.1016\/j.neo.2026.101346_bib0015","doi-asserted-by":"crossref","first-page":"4138","DOI":"10.4161\/cc.10.23.18323","article-title":"Mechanism of action of the multikinase inhibitor Foretinib","volume":"10","author":"Dufies","year":"2011","journal-title":"Cell cycle (Georgetown, Tex.)"},{"key":"10.1016\/j.neo.2026.101346_bib0016","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1158\/0008-5472.CAN-23-1534","article-title":"Foretinib is effective in acute myeloid leukemia by inhibiting FLT3 and overcoming secondary mutations that drive resistance to Quizartinib and Gilteritinib","volume":"84","author":"Wang","year":"2024","journal-title":"Cancer Res."},{"key":"10.1016\/j.neo.2026.101346_bib0017","doi-asserted-by":"crossref","first-page":"757","DOI":"10.3390\/ijms24010757","article-title":"Foretinib is effective against triple-negative breast cancer cells MDA-MB-231 in vitro and in vivo by down-regulating p-MET\/HGF signaling","volume":"24","author":"Ji","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neo.2026.101346_bib0018","doi-asserted-by":"crossref","first-page":"4950","DOI":"10.1111\/jcmm.16362","article-title":"Targeted dual inhibition of c-met\/VEGFR2 signalling by foretinib improves antitumour effects of nanoparticle paclitaxel in gastric cancer models","volume":"25","author":"Grojean","year":"2021","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.neo.2026.101346_bib0019","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2021.100515","article-title":"Citrus-derived DHCP inhibits mitochondrial complex II to enhance TRAIL sensitivity via ROS-induced DR5 upregulation","volume":"296","author":"Chen","year":"2021","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neo.2026.101346_bib0020","doi-asserted-by":"crossref","first-page":"14972","DOI":"10.1021\/acsnano.5c00942","article-title":"Organic radiosensitizer with aggregation-induced emission characteristics for tumor ablation through synergistic apoptosis and immunogenic cell death","volume":"19","author":"Xie","year":"2025","journal-title":"ACS. Nano"},{"key":"10.1016\/j.neo.2026.101346_bib0021","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.canlet.2018.08.028","article-title":"Immunogenic cell death in anticancer chemotherapy and its impact on clinical studies","volume":"438","author":"Wang","year":"2018","journal-title":"Cancer Lett."},{"key":"10.1016\/j.neo.2026.101346_bib0022","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1396349","article-title":"CX3CL1 release during immunogenic apoptosis is associated with enhanced anti-tumour immunity","volume":"15","author":"Naessens","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.neo.2026.101346_bib0023","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1038\/s41568-019-0183-z","article-title":"Phagocytosis checkpoints as new targets for cancer immunotherapy","volume":"19","author":"Feng","year":"2019","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.neo.2026.101346_bib0024","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3001375","article-title":"Calreticulin is the dominant pro-phagocytic signal on multiple human cancers and is counterbalanced by CD47","volume":"2","author":"Chao","year":"2010","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.neo.2026.101346_bib0025","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2020.1795995","article-title":"Lurbinectedin: an FDA-approved inducer of immunogenic cell death for the treatment of small-cell lung cancer","volume":"9","author":"Kepp","year":"2020","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.neo.2026.101346_bib0026","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/s41580-018-0089-8","article-title":"Regulation of apoptosis in health and disease: the balancing act of BCL-2 family proteins","volume":"20","author":"Singh","year":"2019","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.neo.2026.101346_bib0027","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1038\/s41571-020-0341-y","article-title":"Targeting apoptosis in cancer therapy","volume":"17","author":"Carneiro","year":"2020","journal-title":"Nature Rev. Clin. Oncol."},{"key":"10.1016\/j.neo.2026.101346_bib0028","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/s41422-022-00772-1","article-title":"Death receptor 5 rises to the occasion","volume":"33","author":"Zheng","year":"2023","journal-title":"Cell Res."},{"key":"10.1016\/j.neo.2026.101346_bib0029","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1007\/s12272-018-01103-y","article-title":"Elucidation for modulation of death receptor (DR) 5 to strengthen apoptotic signals in cancer cells","volume":"42","author":"Min","year":"2019","journal-title":"Arch. Pharm. Res."},{"key":"10.1016\/j.neo.2026.101346_bib0030","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.trecan.2023.02.001","article-title":"Cell death, therapeutics, and the immune response in cancer","volume":"9","author":"H\u00e4nggi","year":"2023","journal-title":"Trends. Cancer"},{"key":"10.1016\/j.neo.2026.101346_bib0031","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.1016\/j.immuni.2023.08.014","article-title":"Dendritic cells as shepherds of T cell immunity in cancer","volume":"56","author":"Pittet","year":"2023","journal-title":"Immunity"},{"key":"10.1016\/j.neo.2026.101346_bib0032","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2023.216167","article-title":"Improvement strategy for immune checkpoint blockade: a focus on the combination with immunogenic cell death inducers","volume":"562","author":"Shi","year":"2023","journal-title":"Cancer Lett."},{"key":"10.1016\/j.neo.2026.101346_bib0033","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2025.189294","article-title":"CD47 as a potent target in cancer immunotherapy: a review","volume":"1880","author":"Ahvati","year":"2025","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"key":"10.1016\/j.neo.2026.101346_bib0034","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/s41698-023-00418-4","article-title":"Targeting CD47-SIRPa axis shows potent preclinical anti-tumor activity as monotherapy and synergizes with PARP inhibition","volume":"7","author":"Al-Sudani","year":"2023","journal-title":"NPJ. Precis. Oncol."},{"key":"10.1016\/j.neo.2026.101346_bib0035","article-title":"CD47\u2013SIRP\u03b1-targeted therapeutics: status and prospects","volume":"13","author":"Maute","year":"2022","journal-title":"Immuno-Oncol. Technol."},{"key":"10.1016\/j.neo.2026.101346_bib0036","doi-asserted-by":"crossref","first-page":"4715","DOI":"10.3390\/cancers14194715","article-title":"Disulfiram\/copper induces immunogenic cell death and enhances CD47 blockade in hepatocellular carcinoma","volume":"14","author":"Gao","year":"2022","journal-title":"Cancers. (Basel)"},{"key":"10.1016\/j.neo.2026.101346_bib0037","doi-asserted-by":"crossref","first-page":"29189","DOI":"10.1021\/jacs.4c11636","article-title":"PAMAM-based polymeric immunogenic cell death inducer to potentiate cancer immunotherapy","volume":"146","author":"Huang","year":"2024","journal-title":"J. Am. Chem. Soc."}],"container-title":["Neoplasia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1476558626000771?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1476558626000771?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T11:37:44Z","timestamp":1788262664000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1476558626000771"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":37,"alternative-id":["S1476558626000771"],"URL":"https:\/\/doi.org\/10.1016\/j.neo.2026.101346","relation":{},"ISSN":["1476-5586"],"issn-type":[{"value":"1476-5586","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Foretinib triggers immunogenic cell death and enhances efficacy of anti-CD47 immunotherapy in colorectal cancer","name":"articletitle","label":"Article Title"},{"value":"Neoplasia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neo.2026.101346","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"101346"}}